Rights to Results. Společnosti Bayer patří výhradní práva ke všem výsledkům, bez ohledu na jejich formu nebo povahu, bez ohledu na to, zda jsou způsobilé být předmětem patentové ochrany či nikoli, zda jsou hmotné nebo nehmotné (včetně, ale nikoliv pouze, informací, dat, know-how, snímků a vzorků), které vznikly nebo byly jinak učiněné v souvislosti s prováděním Studie Centrem, Zkoušejícím a/nebo Členy studijního týmu nebo jinými stranami zapojenými Smluvními partnery (dále jen „Výsledky“). Smluvní partneři se zavazují postoupit a tímto předem postupují veškerá svá majetková práva k Výsledkům na Bayer a Bayer tato postoupená práva přijímá. Odměna za tento převod je již zahrnuta v odměně Smluvních partnerů dle čl. IV této Smlouvy a činí % z takové odměny. Smluvní partneři nezískávají k Výsledkům plněním této Smlouvy žádná práva. 5.1 Bayer shall own the exclusive rights to all results, whatever their form or nature, whether patentable or not, tangible or intangible (including but not limited to information, data, know-how, images and samples), that are originated or otherwise made in connection with the performance of the Study by Center, Investigator and/or Study Team Members or other parties involved by Contract Partners (hereinafter referred to as "Results"). Contract Partners shall assign and hereby assign their proprietary rights to the Results to Bayer in advance and Bayer accepts such assignment. The remuneration for this assignment is already included in the fee under Art. IV hereof and amounts to % of that fee. Contract Partners shall not acquire any rights to the Results by performing this Agreement.
Rights to Results. In case that results are generated by Advisor including intellectual property rights relating thereto (collectively “Results”) Advisor shall promptly disclose any Results to the Project Leader in writing. All rights, title and interest in any Results will be owned exclusively by the Participants in equal shares, and Advisor shall assign (or cause to be assigned) and does hereby assign fully to each of the Participants in equal shares all rights, title and interest in and to any Results, without payment of any additional compensation to Advisor. At a Participant’s request and expense, Advisor shall also reasonably assist such Participant in obtaining, perfecting, or defending such Participant’s rights, title, and interest in any Results, including, without limitation, the drafting, filing and prosecution of any patent applications. As between the Participants, such results shall be deemed to be [allocate as suitable pursuant to Consortium Agreement terms, e.
Rights to Results. Zmluvní partneri zabezpečia, aby Členovia skúšajúceho tímu postúpili sponzorovi všetky svoje vlastnícke práva na výsledky uvedené v článku 5.
Rights to Results. 13.1 Unless otherwise agreed, the buyer shall gain exclusive proprietary right to the results of the service as it is carried out. All reports, drawings, specifications and similar documents as well as software generated in connection with the service, are parts of the result of the service.
Rights to Results. Should the work performed pursuant to this Agreement generate know-how or copyrightable material, it shall be passed on to BI automatically and at no additional charge for worldwide unrestricted use. The entire copyrights and all other such rights of use as by law or international convention (e. g. design rights, title rights etc.) which subsist in the materials prepared pursuant to this Agreement (including but not limited to drafts and electronic formats thereof) shall be vested in BI, exclusively. Use by BI is unrestricted in terms of territory, time and way of exploitation, especially, but not limited to, publication, distribution, copying, and the right of making available, changes and amendments, editing, translation, synchronisation (where applicable), use and storage by way of printed and audio-visual material and electronic media (CD-ROMs, internet (e.g. as webcast transmissions) data bases and other electronic storage and transmission media. The required consent of the Consultant to the use of recordings is attached as Attachment 3 and forms an integral part of this Agreement. BI shall also be entitled to use the materials in part and to assign its rights in full or in part to third parties. Aforementioned rights are included within the fee set out under Section
2.1. For any publication and disclosure by Contractual Partner or the Consultant the prior written consent by BI is mandatory. All projects, data, experience and inventions resulting from the work pursuant to this Agreement shall become and remain the exclusive property of BI. BI thus retains without further payment all rights without restriction to worldwide commercial use of the relevant products and licences.
Rights to Results. 4.1 The Contractor shall receive all results of the Project in the form of reports. The results of the cooperation, which do not comprise intellectual property rights, may be widely disseminated. The Parties may freely publish on those results, without prejudice to Article 5 of this Agreement.
4.2 All intellectual property rights arising from the activities of the Research Organisation shall be wholly owned by the Research Organisation.
4.3 The Research Establishment may transfer the intellectual property rights resulting from the Project to the Entrepreneur in return for a payment corresponding to the market price of these property rights. Any contribution of the Entrepreneur to the costs of the Research Institution shall be deducted from the aforementioned fee.
Rights to Results. Společnosti AOP Orphan Pharmaceuticals AG patří výhradní práva ke všem výsledkům, datům, zjištěním, radiologickým a diagnostickým snímkům, objevům, vynálezům a specifikacím, bez ohledu na to, zda jsou způsobilé být předmětem patentové ochrany či nikoli, které vznikly, byly vytvořené, odvozené, vyprodukované, objevené, vymyšlené nebo jinak učiněné Centrem, Zkoušejícím a/nebo členy Zkušebního týmu lékařů v souvislosti s prováděním Studie (dále jen „Výsledky“). Smluvní partneři tímto předem postupují veškerá svá majetková práva k Výsledkům na společnost AOP Orphan Pharmaceuticals AG a AOP Orphan Pharmaceuticals AG tato postoupená práva přijímá. Odměna za tento převod je již zahrnuta v odměně Smluvních partnerů dle čl. 4. a činí 5 % z takové odměny.
Rights to Results. Smluvní strany se dohodly, že s výjimkou případů výslovně stanovených v této Smlouvě Zadavatel, Medpace, zkoušející lékař ani Zdravotnické zařízení v rámci provádění této Smlouvy nepřevedou jakákoli patentová či autorská práva, práva k ochranným známkám ani jiná vlastnická práva Zadavatele, Medpace, zkoušejícího nebo Zdravotnického zařízení na kohokoli jiného. Zadavateli patří výhradní práva ke všem výsledkům, datům, zjištěním, objevům, vynálezům a specifikacím, bez ohledu na to, zda jsou způsobilé být předmětem patentové ochrany či nikoli, které vznikly, byly vytvořené, odvozené, vyprodukované, objevené, vymyšlené nebo jinak učiněné Zdravotnickým zařízením, Hlavním zkoušejícím a/nebo Členy studijního týmu v souvislosti s prováděním Studie (dále jen „Výsledky“). Smluvní partneři tímto předem postupují veškerá svá majetková práva k Výsledkům na Zadavatele. Odměna za tento převod je již zahrnuta v odměně Smluvních partnerů dle čl. 4. Smluvní partneři nezískávají k Výsledkům plněním této Smlouvy žádná práva.
Rights to Results. All information or material, whether protected or otherwise, which has been identified as a result and which stems from the collaboration subject to this agreement, will be considered results of the collaboration. Insofar as the results obtained are subject to legal protection by means of a patent or other intellectual and industrial property rights, the parties will enter into a co-ownership agreement that will establish the terms of this agreement and that will mention as inventors or authors the members of the parties who have intellectually contributed to obtaining the results in question. Both parties undertake to cooperate insofar as it is necessary to achieve the enforceability of the rights recognised in the aforementioned co-ownership agreement. This cooperation includes obtaining the signature of the inventors or authors responsible for the research of the documents necessary for processing intellectual or industrial property rights, as well as their extension to other countries when this is decided upon. The parties will have the exploitation rights over the results of the collaboration under the conditions established in the co-ownership agreement. If a party is interested in exploiting the results, it must notify the other party, via a registered letter, of its decision to do so, whether it intends to do it by itself or through authorised third parties.
Rights to Results. Should the work performed pursuant to this Agreement generate know-how or copyrightable material, it shall be passed on to BI automatically and at no additional charge for worldwide unrestricted use. The entire copyrights and all other such rights of use as by law or international convention (e. g. design rights, title rights etc.) which subsist in the materials prepared pursuant to this Agreement (including but not limited to drafts and electronic formats thereof) shall be vested in BI, exclusively. Use by BI is unrestricted in terms of territory, time and way of exploitation, especially, but not limited to, publication, distribution, copying, and the right of making available, changes and amendments, editing, translation, synchronisation (where applicable), use and storage by way of printed and audio-visual material and electronic media (CD-ROMs, internet (e.g. as webcast transmissions) data bases and other electronic storage and transmission media. BI shall also be entitled to use the materials in part and to assign its rights in full or in part to third parties. Aforementioned rights are included within the fee set out under Section 2.1. For any publication and disclosure by Contractual Partner or the Consultant the prior written consent by BI is mandatory. All projects, data, experience and inventions resulting from the work pursuant to this Agreement shall become and remain the exclusive property of BI. BI thus retains without further payment all rights without restriction to worldwide commercial use of the relevant products and licences.
